Incyte Corp. logo

INCY

Incyte Corp.

$73.94

Earnings Summary

Revenue
$911.4Mn
Net Profits
$161.43Mn
Net Profit Margins
17.71%
PE Ratio
17.67

Highlights

Revenue:

Incyte Corp.’s revenue jumped 29.15% since last year same period to $911.4Mn in the Q2 2022. On a quarterly growth basis, Incyte Corp. has generated 24.3% jump in its revenue since last 3-months.

Net Profits:

Incyte Corp.’s net profit jumped 8.01% since last year same period to $161.43Mn in the Q2 2022. On a quarterly growth basis, Incyte Corp. has generated 324.91% jump in its net profits since last 3-months.

Net Profit Margins:

Incyte Corp.’s net profit margin fell -16.36% since last year same period to 17.71% in the Q2 2022. On a quarterly growth basis, Incyte Corp. has generated 241.85% jump in its net profit margins since last 3-months.

PE Ratio:

Incyte Corp.’s price-to-earnings ratio after this Q2 2022 earnings stands at 17.67.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Incyte Corp. post its latest quarter earnings

EPS Estimate Current Quarter
0.84
EPS Estimate Current Year
0.84

Highlights

EPS Estimate Current Quarter:

Incyte Corp.’s earning per share (EPS) estimates for the current quarter stand at 0.84 - a 10.53% jump from last quarter’s estimates.

EPS Estimate Current Year:

Incyte Corp.’s earning per share (EPS) estimates for the current year stand at 0.84.

Key Ratios

Key ratios of the Incyte Corp. post its Q2 2022 earnings

Earning Per Share (EPS)
1.01
Return on Assets (ROA)
0.1
Return on Equity (ROE)
0.27
Dividend Per Share (DPS)
0

Highlights

Earning Per Share (EPS):

Incyte Corp.’s earning per share (EPS) jumped 26.25% since last year same period to 1.01 in the Q2 2022. This indicates that the Incyte Corp. has generated 26.25% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Incyte Corp.’s return on assets (ROA) stands at 0.1.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Incyte Corp.’s return on equity (ROE) stands at 0.27.

Dividend Per Share (DPS):

Incyte Corp. declared 0 dividend per share during the earnings announcement for Q2 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-05-03
0.67
0.55
-17.91%
2022-08-02
0.76
1.01
32.89%

Company Information

Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics.

Organisation
Incyte Corp.
Headquarters
Wilmington, Delaware, US
Employees
1.77K
Industry
Health Technology
CEO
Paul Friedman